Harsahaj Singh Wilkhoo | Neurology | Best Scholar Award

Published on by Academic Excellence

Mr. Harsahaj Singh Wilkhoo | Neurology | Best Scholar Award

Mr. Harsahaj Singh Wilkhoo, Tbilisi State Medical University, Georgia

Harsahaj Singh Wilkhoo is a dynamic and passionate final-year medical student at Tbilisi State Medical University. He has consistently demonstrated academic excellence, maintaining a GPA above 3.4, and actively engaging in medical education, research, and global healthcare innovation. As the founder and director of ClinNova International, he has empowered over 1,000 international medical students through mentorship, symposiums, and research workshops. His past leadership at GCMER Georgia impacted more than 10,000 students and professionals across 11+ countries. He is a certified Diabetes Educator by the International Diabetes Federation and an active member of the American College of Lifestyle Medicine. With 22+ research contributions, peer-reviewed publications, and conference presentations, his interests span neurology, endocrinology, stroke, and lifestyle medicine. A peer reviewer for academic journals, he envisions a future where interdisciplinary collaboration and AI will reshape global medical education and patient care.

Profile

Scopus

Orcid

Summary of Suitability:

Harsahaj Singh Wilkhoo exemplifies the essence of a “Best Scholar” through a rare combination of academic rigor, leadership, research engagement, and social impact. As a senior medical student at Tbilisi State Medical University, his sustained GPA of over 3.4 reflects his consistent academic performance. However, his true scholarly distinction lies beyond grades—in his bold initiatives that have transformed student research and peer learning on a global scale.

As the Founder and Director of ClinNova International, he has established a pioneering peer education and research platform that has empowered over 1,000 medical students in just six months. His role in organizing major academic events and nurturing clinical and research skills among cohorts of students positions him as a visionary mentor in the global medical education ecosystem. His earlier tenure as President of GCMER Georgia further highlights his leadership in building operational teams, launching campus initiatives, and organizing national and international academic conferences with far-reaching impact.

🎓 Education 

Harsahaj Singh Wilkhoo is currently pursuing his final semester in the M.D. program at Tbilisi State Medical University, Georgia, where he maintains a GPA exceeding 3.4. His education reflects a strong foundation in clinical sciences, medical ethics, and research methodology. His academic journey is marked by active participation in various student-led research clubs, academic fairs, and national student surgical conferences. He has received extensive training in clinical skills and has developed a particular focus on stroke, endocrinology, and lifestyle-related neurological disorders. Harsahaj has also completed international certifications, notably from the International Diabetes Federation School of Diabetes, which equipped him with advanced knowledge in diabetes management. He complements his formal education with online mentorship programs and research training cohorts that he organizes and leads. Through his educational journey, he continuously integrates theoretical learning with practical experience and global health exposure.

💼 Professional Experience 

Harsahaj Singh Wilkhoo is the Founder and Director of ClinNova International, a platform that fosters peer education and research among global medical students. Since 2024, he has managed a diverse team of 76 medical professionals, conducted workshops, and led events such as Cardioqest Symposium 2025 and Orthoconvergence 2025. He formerly served as President of GCMER Georgia (2021–2024), organizing large-scale academic events, mentoring over 1,000 students, and coordinating with 10+ universities. His earlier contributions include mentoring for GCMER HQ’s Journal Club, and working with the TSMU Academic Department where he organized major student-centered academic fairs and conferences. He is also a peer reviewer for Cureus Journal of Medical Science, and has freelanced as a proofreader/editor via Fiverr. Harsahaj excels in event execution, research mentorship, clinical education, and strategic leadership. His multidisciplinary roles highlight a rare blend of vision, initiative, and collaborative excellence.

🏅 Awards and Recognition 

Harsahaj Singh Wilkhoo has earned widespread recognition for his leadership and educational impact in international medical communities. Under his leadership, ClinNova International and GCMER Georgia have received acclaim for large-scale medical symposiums and research mentoring events, including Elixir 2023 and IMAUC 2023. He was certified as a Diabetes Educator by the International Diabetes Federation, Belgium, and his contributions have been highlighted in academic and public health discussions. He has organized over 10 flagship symposiums across diverse topics such as Onconexus, DiaConnect, and Neuro 2023, with hundreds of participants and over 100 research abstracts/posters showcased. He has also served as a peer reviewer for Cureus and other journals—an acknowledgment of his academic maturity and research insight. Through his mentorship and research training programs, he has impacted the careers of more than 1,000 medical students globally. His awards reflect dedication, interdisciplinary leadership, and academic contribution.

🌍 Research Skills On Neurology

Harsahaj Singh Wilkhoo possesses advanced research skills developed through involvement in over 22 research projects, peer-reviewed publications, and conference presentations. His expertise spans from neurological disorders and stroke to diabetes, cardiology, medical tourism, and lifestyle medicine. He has trained numerous students in research methodology, literature review, data analysis, scientific writing, and publication processes. As a peer reviewer at Cureus, he brings critical appraisal skills and editorial insight. He has hosted multiple abstract writing and poster presentation competitions, strengthening his skills in academic communication and event evaluation. Harsahaj leads research training cohorts that build capacity among students to publish and present in international conferences. His work reflects a keen understanding of clinical epidemiology, biostatistics, and ethical compliance. He believes in integrating artificial intelligence and interdisciplinary methods to solve healthcare challenges. His strategic approach, technical depth, and mentoring ability distinguish him as a research-oriented medical innovator.

📖 Publication Top Notes

Chandipura Vesiculovirus: Clinical Manifestation, Neuroinvasion and Public Health Interventions

  • Author(s): Harsahaj Singh Wilkhoo

  • Citation: Wilkhoo, H. S. (2024). Chandipura Vesiculovirus: Clinical Manifestation, Neuroinvasion and Public Health Interventions. International Journal of Health Sciences and Research.

  • Year: 2024 (Published on 2024-09-02)

Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management

  • Author(s): Harsahaj Singh Wilkhoo, Afra Wasama Islam, Felcia Reji, Rhea Potdar, Labdhi Sanghvi, Siddhant Solanki

  • Citation: Wilkhoo, H. S., Islam, A. W., Reji, F., Potdar, R., Sanghvi, L., & Solanki, S. (2024). Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management. Discoveries Journal.

  • Year: 2024 (Published on 2024-07-13)

Comparison of Impact of High versus Low FODMAPs diet on Gut Flora in Patients with Irritable Bowel Syndrome

  • Author(s): Afra Wasama Islam, Harsahaj Singh Wilkhoo

  • Citation: Islam, A. W., & Wilkhoo, H. S. (2024). Comparison of Impact of High versus Low FODMAPs diet on Gut Flora in Patients with Irritable Bowel Syndrome. International Journal of Progressive Sciences and Technologies.

  • Year: 2024 (Published on 2024-07-02)

Association of gut dysbiosis with potential mechanisms leading to atrial fibrillation: A narrative review

  • Author(s): Harsahaj Singh Wilkhoo

  • Citation: Wilkhoo, H. S. (2024). Association of gut dysbiosis with potential mechanisms leading to atrial fibrillation: A narrative review. International Journal of Innovative Science and Research Technology.

  • Year: 2024 (Published on 2024-05-16)

 

 

Scheherazade Le | Neuroscience | Best Researcher Award

Published on by Academic Excellence

Dr. Scheherazade Le | Neuroscience | Best Researcher Award

👤 Dr. Scheherazade Le, Stanford, United States

Dr. Scheherazade Le, M.D., is a Clinical Professor in the Department of Neurology at Stanford University. With expertise in epilepsy and electroencephalography (EEG), she specializes in intraoperative neuromonitoring (IONM) and neurophysiology. Dr. Le earned her M.D. from the University of California, San Francisco (UCSF), and completed residency and fellowship training at Stanford University, where she also held the role of Chief Resident. With extensive clinical and academic appointments, Dr. Le is dedicated to advancing medical education in neurology. Her contributions extend to the creation of high-quality teaching curricula and the mentorship of students, residents, and fellows. Her clinical expertise and passion for education have earned her multiple honors, including the A.B. Baker Teacher Recognition Award. Through her innovative teaching and research, Dr. Le has made significant contributions to the field of neuroscience.

Professional Profile

Scopus

🌟 Research for Best Researcher Award Evaluation for Dr. Scheherazade Le, M.D.

Dr. Scheherazade Le, a Clinical Professor in the Department of Neurology at Stanford University, is an exemplary candidate for the Research for Best Researcher Award. Her extensive background in epilepsy, electroencephalography (EEG), and intraoperative neuro-monitoring (IONM) sets her apart as a leader in the field. She holds dual board certifications in adult neurology and epilepsy, which reflect her comprehensive expertise.

Dr. Le’s education and training at prestigious institutions like UCSF and Stanford, coupled with her multiple academic appointments and contributions to the curriculum, have been highly influential. Her role as the co-course director of Stanford’s Neuroscience Block and her efforts in developing innovative neurology curriculum, especially for epilepsy, reflect her deep commitment to advancing education in the medical field. She has consistently received recognition for her excellence in teaching, receiving numerous awards such as the A.B. Baker Teacher Recognition Award from the American Academy of Neurology in 2024.

🎓 Education 

Dr. Scheherazade Le completed her M.D. at the University of California, San Francisco (UCSF) in May 2006, where she focused on medical humanities. Her undergraduate studies were at the University of California, Berkeley (UCB), where she graduated with High Honors in Political Science and received the highest honors for her thesis. Dr. Le pursued residency in Neurology at Stanford University, where she also served as Chief Resident. Afterward, she completed fellowship training in Clinical Neurophysiology at Stanford, specializing in Intraoperative Neuro-Monitoring (IONM) and Epilepsy & Electroencephalography (EEG). Dr. Le’s academic achievements are reflected in her continuous commitment to excellence in teaching and mentoring. She has significantly contributed to shaping the neurology curriculum at Stanford Medical School and has earned numerous awards, such as the A.B. Baker Teacher Recognition Award, further demonstrating her academic prowess and passion for education.

💼   Professional Experience 

Dr. Scheherazade Le currently serves as a Clinical Professor at the Department of Neurology at Stanford University, where she is responsible for teaching and supervising medical students, residents, and fellows in epilepsy, electroencephalography (EEG), and intraoperative neuromonitoring (IONM). Her professional trajectory includes various roles at Stanford University, ranging from Clinical Assistant Professor to Clinical Associate Professor. Throughout her tenure, she has led educational initiatives and clinical training for Stanford’s Neurology residency and fellowship programs. Dr. Le has been instrumental in course development for the Neuroscience Block (SOM223A), a second-year medical school course that she co-directs. She is also an invited lecturer for the Stanford Physician Assistant Program and actively participates in the Epilepsy Monitoring Unit. Dr. Le’s clinical work involves treating patients with epilepsy, neurophysiological conditions, and neurological disorders, while her academic efforts focus on curriculum development and innovative teaching methodologies.

🏅  Awards and Recognition 

Dr. Scheherazade Le has been recognized with numerous prestigious awards throughout her career. She was nominated for the American Academy of Neurology (AAN) Neuroscience Course Director Excellence Award in 2025 and received the A.B. Baker Teacher Recognition Award in 2024. Her commitment to educational excellence is further demonstrated by her receipt of the Stanford School of Medicine’s highest-rated course award for the Neuroscience Block (SOM223), which she has received multiple times, including in 2023 and 2024. Dr. Le’s work in neurology education also garnered her the Henry J. Kaiser Family Foundation Teaching Award Nominee for her contributions to medical education from 2022 to 2023. Other accolades include the Stanford Department of Neurology Lysia S. Forno Teaching Award and the Stanford Neurology Clerkship Medical Student Teaching Award. These honors reflect her dedication to advancing both the academic and clinical training of the next generation of neurologists.

🌍 Research Skill On Neuroscience

Dr. Scheherazade Le’s research interests lie at the intersection of clinical neurophysiology, epilepsy, and neuroimaging. She is particularly focused on advancing understanding and treatment methodologies for epilepsy and neurologic diseases through the use of electroencephalography (EEG) and intraoperative neuro-monitoring (IONM). Dr. Le’s research has contributed to the growing body of knowledge regarding brain-responsive neurostimulation in epilepsy patients with tuberous sclerosis complex. Additionally, she has been involved in studies concerning autoimmune encephalitis, psychogenic non-epileptic seizures, and the neurophysiology of abnormal movements. Her ability to bridge clinical practice with scientific investigation allows her to translate complex research findings into effective clinical treatments. Dr. Le is a key collaborator in multi-disciplinary research projects and has presented her work at regional neurophysiology and neuroimmunology conferences. Her ongoing research aims to improve diagnostic approaches and develop innovative therapies for neurological disorders, impacting both clinical practice and patient care.

 📖 Publication Top Notes

  • Cognitive and behavioral effects of perampanel 4 mg daily dose
    Authors: Meador, K.J., Seliger, J., Le, S., Loring, D.W., Gerard, E.
    Journal: Epilepsy and Behavior
    Year: 2025
    Volume: 164
  • Response to “Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration”
    Authors: Folmsbee, S.S., Gombar, S., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 126
  • Amnesia, Superior Altitudinal Anopia, and Reversed Clock Phenomenon due to Bilateral Posterior Cerebral Artery Infarcts
    Authors: Jindal, J.A., Le, S.T., Lansberg, M.G.
    Journal: Stroke
    Year: 2024
    Volume: 55(6)
  • Antipsychotic medications associated with increased length of hospital stay in autoimmune encephalitis and multiple sclerosis: A retrospective study
    Authors: Sai Folmsbee, S., Hui, G., Yuan, Y., Han, M., Le, S.
    Journal: Journal of Clinical Neuroscience
    Year: 2024
    Volume: 124
  • Utilization of APE2 and RITE2 scores in autoimmune encephalitis patients with seizures
    Authors: Rafferty, T., Koeppen-Babcock, A., Muppidi, S., Li, Y., Le, S.
    Journal: Epilepsy and Behavior
    Year: 2024
    Volume: 154
  • Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: A multi-centre cohort study
    Authors: Youngerman, B.E., Banu, M.A., Khan, F., D’Haese, P.-F., Wu, C.
    Journal: Journal of Neurology, Neurosurgery and Psychiatry
    Year: 2023
    Volume: 94(11)
  • Sharps Injuries Related to Subdermal Needles in the Orbicularis Oris During Intraoperative Neurophysiologic Monitoring
    Authors: Joshi, A., Aissa, Y., Le, S., Lee, L., Lopez, J.R.
    Journal: Journal of Clinical Neurophysiology
    Year: 2022
    Volume: 39(7)
  • A retrospective cohort study of new-onset refractory status epilepticus (NORSE): clinical features, timing of immunotherapy and outcomes
    Authors: Werbaneth, K., Mausolf, M., Seliger, J., Le, S.
    Journal: Epileptic Disorders
    Year: 2022
    Volume: 24(5)
  • Direct brainstem somatosensory evoked potentials for cavernous malformations
    Authors: Le, S., Nguyen, V., Lee, L., Steinberg, G., López, J.
    Journal: Journal of Neurosurgery
    Year: 2022
    Volume: 137(1)
  • Hybrid Fluoroscopic and Neurophysiological Targeting of Responsive Neurostimulation of the Rolandic Cortex
    Authors: Parker, J.J., Jamiolkowski, R.M., Grant, G.A., Le, S., Halpern, C.H.
    Journal: Operative Neurosurgery
    Year: 2021
    Volume: 21(3)